Ralliant (NYSE:RAL) SVP Karen Bick Sells 6,062 Shares

Key Points

• Insider sale: SVP Karen Bick sold 6,062 Ralliant shares at an average price of $72, totaling $436,464, reducing her direct ownership by 16.07% to 31,668 shares. The transaction was conducted under a pre-arranged Rule 10b5-1 plan.
• Stock and earnings: Ralliant shares recently traded at $69.42, while the company reported quarterly EPS of $0.68, exceeding analyst expectations of $0.63, on revenue of $567.8 million.
• Investor outlook: Analysts maintain a “Moderate Buy” consensus with an average price target of $75.70. Ralliant also declared a quarterly dividend of $0.05 per share, implying a 0.3% annualized yield.

Ralliant Corporation (NYSE:RAL - Get Free Report) SVP Karen Bick sold 6,062 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president directly owned 31,668 shares in the company, valued at approximately $2,280,096. This trade represents a 16.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ralliant Price Performance

Shares of NYSE RAL traded down $2.54 during mid-day trading on Tuesday, reaching $69.42. The company had a trading volume of 1,336,205 shares, compared to its average volume of 1,694,804. The firm has a market cap of $7.68 billion, a price-to-earnings ratio of -6.40, a PEG ratio of 2.69 and a beta of 1.61. The business's 50-day simple moving average is $68.82 and its 200 day simple moving average is $55.58. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52.

Ralliant (NYSE:RAL - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, research analysts predict that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant's dividend payout ratio (DPR) is currently -1.84%.

Institutional Trading of Ralliant

A number of hedge funds have recently added to or reduced their stakes in RAL. Empowered Funds LLC acquired a new position in shares of Ralliant during the second quarter worth $8,262,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Ralliant during the 2nd quarter valued at $2,474,000. Corient Private Wealth LP bought a new stake in Ralliant during the 2nd quarter worth $2,570,000. Bank of America Corp DE bought a new stake in Ralliant during the 2nd quarter worth $42,001,000. Finally, Freestone Grove Partners LP acquired a new position in Ralliant in the 2nd quarter worth about $15,211,000.

Analysts Set New Price Targets

Several brokerages have commented on RAL. Morgan Stanley boosted their price objective on shares of Ralliant from $68.00 to $85.00 and gave the company an "overweight" rating in a research report on Tuesday, June 23rd. Truist Financial reiterated a "buy" rating and issued a $82.00 price target (up from $68.00) on shares of Ralliant in a research note on Friday, July 31st. Evercore initiated coverage on Ralliant in a report on Tuesday, June 9th. They set an "outperform" rating and a $80.00 price target for the company. Citigroup upped their price objective on Ralliant from $81.00 to $82.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Finally, Wall Street Zen cut Ralliant from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $75.70.

About Ralliant

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source